Google Scholar citation report
Citations : 16585

Journal of Basic and Clinical Pharmacy received 16585 citations as per google scholar report

Indexed In

Hun Beon*
 
Department of Cardiology and Neurology, Kyung Hee University, Seoul, South Korea
 
*Correspondence: Hun Beon, Department of Cardiology and Neurology, Kyung Hee University, Seoul, South Korea, Email: beon@gmail.kr

Received: 30-Sep-2024, Manuscript No. jbclinphar-24-153964; Editor assigned: 02-Oct-2024, Pre QC No. jbclinphar-24-153964(PQ); Reviewed: 16-Oct-2024 QC No. jbclinphar-24-153964 ; Revised: 23-Oct-2024, Manuscript No. jbclinphar-24-153964 (R); Published: 30-Oct-2024

Citation: Lie Y. The Rise of Herbal Medicines: A Global Perspective. J Basic Clin Pharma.2024,15(5):386.

This open-access article is distributed under the terms of the Creative Commons Attribution Non-Commercial License (CC BY-NC) (http://creativecommons.org/licenses/by-nc/4.0/), which permits reuse, distribution and reproduction of the article, provided that the original work is properly cited and the reuse is restricted to noncommercial purposes. For commercial reuse, contact reprints@jbclinpharm.org

Description

Herbal medicines have been used for centuries across cultures as remedies for various ailments. In recent decades, their popularity has surged globally, with many people viewing them as safe and natural alternatives to conventional pharmaceuticals. However, the rising use of herbal medicines brings a critical need for pharmacovigilance to monitor their safety and effectiveness. Unlike modern drugs, herbal medicines face unique challenges in this domain, complicating efforts to ensure they are both safe and efficacious.

Herbal medicines encompass a wide range of plant-derived products, including teas, tinctures, capsules, and topical preparations. Their popularity stems from a belief in their natural origin, cultural traditions, and accessibility. Additionally, the marketing of these products often emphasizes their traditional use, creating an impression of inherent safety. Herbal medicines are complex mixtures of multiple compounds, many of which have not been fully identified or studied. Unlike synthetic drugs with a single active ingredient, the synergistic or antagonistic interactions among the compounds in herbal products can complicate their pharmacological effects. Such variability poses significant challenges for pharmacovigilance, as identifying the active ingredients responsible for therapeutic or adverse effects becomes difficult. Herbal medicines often fall into regulatory gray areas. In many countries, they are categorized as dietary supplements or traditional remedies rather than drugs, subjecting them to less stringent regulatory oversight. Limited pre-market testing for safety and efficacy.

Adulteration and contamination of herbal medicines are significant concerns. Reports of herbal products containing undisclosed pharmaceutical drugs, heavy metals, pesticides, or microbial contaminants are not uncommon. Such issues arise from poor manufacturing practices and lack of stringent quality control measures. Adulterated herbal products have been found to contain corticosteroids, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), or other synthetic pharmaceuticals to enhance efficacy deceptively. Heavy metals such as lead, arsenic, and mercury have been detected in traditional remedies, posing serious health risks. Pharmacovigilance systems must address these risks by implementing robust quality assurance protocols and ensuring compliance with manufacturing standards.

Herbal medicines can interact with conventional pharmaceuticals, altering their pharmacokinetics or pharmacodynamics. Such interactions can lead to reduced efficacy or increased toxicity of the co-administered drugs. The identification and monitoring of drug-herb interactions are critical but underdeveloped areas within pharmacovigilance. Consumers often perceive herbal medicines as completely safe, leading them to overlook or dismiss adverse effects.

Cultural and traditional beliefs often play a significant role in the use of herbal medicines. While these beliefs promote acceptance and use, they can also hinder pharmacovigilance efforts. Consumers may be reluctant to report adverse effects due to cultural stigmas or a fear of discrediting traditional practices. Funding and resources for studying herbal medicines are often limited compared to conventional drugs. Standardized formulations for clinical testing are difficult to develop due to the variability of herbal products. Traditional usage and anecdotal evidence are often considered sufficient proof of efficacy, reducing the perceived need for rigorous testing. Governments and regulatory bodies must establish clear guidelines for the manufacture, labelling, and sale of herbal medicines. Pre-market safety and efficacy testing. Good Manufacturing Practices (GMP) to prevent contamination and adulteration. Mandatory adverse event reporting systems for herbal medicines.

Raising awareness about the potential risks of herbal medicines among consumers and healthcare professionals is essential. Training programs for healthcare providers can enhance their ability to identify and report adverse events related to herbal products. Investing in research to understand the pharmacological properties, interactions, and longterm safety of herbal medicines is essential. Collaboration between traditional medicine practitioners and modern scientists can bridge knowledge gaps and enhance the evidence base. Using digital tools and artificial intelligence for data collection and analysis can improve pharmacovigilance efforts. Social media and mobile health apps can also serve as platforms for reporting adverse events and educating the public.

Conclusion

Herbal medicines hold significant therapeutic potential but are not without risks. Pharmacovigilance plays a vital role in ensuring their safety and effectiveness, yet it faces numerous challenges unique to the nature of herbal products. Addressing these challenges requires a multifaceted approach involving regulatory reforms, education, research, and technological innovation. By strengthening pharmacovigilance systems, we can maximize the benefits of herbal medicines while minimizing their risks, ensuring they remain a valuable component of global healthcare.